Pharmaceutical tablets are one of the most commonly used dosage forms in medicine. They are convenient and easy to use, making them popular among patients. Metformin is an oral diabetes medicine that helps control blood sugar levels. It is used to treat type 2 diabetes and is often prescribed in combination with other medications. Amoxicillin is a type of antibiotic used to treat a wide range of bacterial infections. It works by killing the bacteria that cause the infection. Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) that helps relieve pain, reduce fever, and reduce inflammation. It is commonly used to treat headaches, muscle pain, and menstrual cramps. Paracetamol is also a pain reliever and fever reducer commonly used for headaches and other minor aches and pains. It is often combined with other medications for stronger pain relief.
Indian Market Outlook
India is one of the fastest-growing pharmaceutical markets globally, with an estimated market size of over USD 40 billion. The Indian pharmaceutical market comprises various segments such as formulations, APIs, vaccines, and biopharmaceuticals. However, among all these segments, pharmaceutical tablets hold the largest share in the Indian pharmaceutical market. The demand for pharmaceutical tablets in the Indian market is driven by factors such as an increase in chronic diseases, the availability of affordable and high-quality drugs, and the rise in government initiatives for healthcare. Additionally, technological advancements in tablet manufacturing processes have also helped the Indian pharmaceutical tablets market to grow rapidly.
Global Market Outlook
The global pharmaceutical tablets market has experienced a tremendous boom over the past few years and is expected to continue to grow at a steady pace in the foreseeable future. The pharmaceutical tablets market is projected to reach $652 billion by 2026, with a CAGR of 3.7% from 2021 to 2026. The major driving forces behind this growth include the rising demand for effective and convenient drug delivery methods, increasing chronic diseases, and advancements in pharmaceutical technologies. One of the major advantages of pharmaceutical tablets is that they are easy to consume, store and transport. Unlike other forms of medication, such as injections or liquids, tablets are less likely to spill or get damaged during transportation. Additionally, pharmaceutical tablets can be made in different sizes, shapes, and colors, making it easier for consumers to identify them. The increasing prevalence of chronic diseases, such as cancer, diabetes, and cardiovascular diseases, is also driving the growth of the pharmaceutical tablets market. With the rising incidence of these diseases, the demand for medication has also increased, creating a need for more convenient and effective drug delivery systems. Pharmaceutical tablets have proven to be a viable solution for such needs, and the market for them has seen a rapid expansion in recent years.
Lastly, advancements in pharmaceutical technologies have also contributed significantly to the growth of the pharmaceutical tablets market. The use of new techniques and materials, such as 3D printing and nanotechnology, has enabled manufacturers to produce more advanced and efficient tablets, increasing their efficacy and ease of use.
Conclusion
Pharmaceutical tablets is expected to continue to grow due to the increasing demand for medications for chronic diseases, an aging population, and increasing awareness of healthcare. The market for Metformin, Amoxicillin, Ibuprofen, and Paracetamol in tablet form is expected to grow due to their proven efficacy in treating various health conditions. The tablets are also highly convenient for the manufacturers to produce, making them a cost-effective solution for pharmaceutical companies. As the demand for easy-to-use medication grows, the Pharmaceutical Tablets Unit industry is rapidly expanding to meet the needs of the market.
Key Players
ü Sun Pharmaceutical Industries
ü Lupin Limited
ü Cadila Healthcare
ü Torrent Pharmaceuticals
ü Cipla Ltd
Cost Estimation
Capacity:
Metformin Tablets (500 mg) 18,750 Th.Nos. Per Annum
Metformin Tablets (850 mg) 18,750 Th.Nos. Per Annum
Amoxicillin Tablets (500 mg) 37,500 Th.Nos. Per Annum
Ibuprafen Tablets (500 mg) 37,500 Th.Nos. Per Annum
Paracetamol Tablets (500 mg) 37,500 Th.Nos. Per Annum
